Fady Ibraham Malik, Executive Vice President, Research & Development, on August 18, 2026, sold 3,500 shares in Cytokinetics (CYTK) for $265,370. Following the Form 4 filing with the SEC, Malik has control over a total of 153,902 common shares of the company, with 153,902 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1061983/000106198326000088/xslF345X05/form4.xml
Cynthia L Feldmann, Director, on August 13, 2026, sold 1,000 shares in Ufp Technologies (UFPT) for $324,260. Following the Form 4 filing with the SEC, Feldmann has control over a total of 4,476 common shares of the company, with 4,476 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/914156/000208495626000058/xslF345X05/form4.xml
Benjamin Wood, Chief Operating Officer, on August 14, 2026, executed a purchase for 25,700 shares in Cardinal Infrastructure Group (CDNL) for $1,014,594. Following the Form 4 filing with the SEC, Wood has control over a total of 45,700 Class A common shares of the company, with 45,700 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/2079999/000121390026090850/xslF345X05/ownership.xml
Ivy Zelman, Director, on August 14, 2026, executed a purchase for 12,647 shares in Cardinal Infrastructure Group (CDNL) for $500,948. Following the Form 4 filing with the SEC, Zelman has control over a total of 32,891 Class A common shares of the company, with 32,891 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/2079999/000121390026090852/xslF345X05/ownership.xml